See more : Qiagen N.V. (QIA.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Cronos Group Inc. (CRON.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cronos Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Space Value Holdings Co., Ltd. (1448.T) Income Statement Analysis – Financial Results
- Lokesh Machines Limited (LOKESHMACH.NS) Income Statement Analysis – Financial Results
- LX Semicon Co., Ltd. (108320.KQ) Income Statement Analysis – Financial Results
- Avix Technologies, Inc. (AVIX) Income Statement Analysis – Financial Results
- Ningbo Shimao Energy Co.,Ltd (605028.SS) Income Statement Analysis – Financial Results
Cronos Group Inc. (CRON.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thecronosgroup.com
About Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 87.24M | 91.90M | 74.44M | 46.72M | 23.75M | 11.53M | 3.25M | 412.32K | 226.59K | 0.00 | -195.61K |
| Cost of Revenue | 75.33M | 79.94M | 91.97M | 72.55M | 41.61M | 3.26M | -2.50M | -1.07M | 144.98K | 32.16K | 0.00 |
| Gross Profit | 11.91M | 11.97M | -17.53M | -25.83M | -17.86M | 8.27M | 5.75M | 1.48M | 81.61K | -32.16K | -195.61K |
| Gross Profit Ratio | 13.65% | 13.02% | -23.56% | -55.29% | -75.22% | 71.76% | 177.12% | 359.61% | 36.02% | 0.00% | 100.00% |
| Research & Development | 5.84M | 13.38M | 23.33M | 20.37M | 12.16M | 1.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 58.23M | 86.29M | 106.63M | 95.89M | 60.99M | 15.90M | 7.00M | 2.78M | 1.47M | 2.02M | 0.00 |
| Selling & Marketing | 22.70M | 22.28M | 44.94M | 34.39M | 23.05M | 3.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 80.93M | 108.58M | 151.57M | 130.28M | 84.04M | 18.92M | 7.00M | 2.78M | 1.47M | 2.02M | 423.86K |
| Other Expenses | 9.93M | 6.03M | 4.48M | 2.87M | 2.10M | 922.15K | 430.22K | 284.76K | 81.66K | 207.54K | 0.00 |
| Operating Expenses | 96.71M | 127.98M | 179.39M | 153.51M | 98.29M | 21.57M | 7.43M | 3.07M | 1.55M | 2.22M | 423.86K |
| Cost & Expenses | 172.04M | 207.92M | 271.35M | 226.07M | 139.91M | 24.82M | 4.92M | 2.00M | 1.69M | 2.26M | 423.86K |
| Interest Income | 51.24M | 22.54M | 9.07M | 18.60M | 36.32M | 0.00 | 3.20K | 4.92K | 29.97K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 22.54M | 27.00K | 186.00K | 1.24M | 78.56K | 100.20K | 177.27K | 325.17K | 0.00 | 0.00 |
| Depreciation & Amortization | 8.11M | 17.08M | 19.31M | 9.45M | 5.19M | 2.51M | 996.00K | 382.75K | 81.66K | 28.11K | 0.00 |
| EBITDA | -71.80M | -91.27M | -192.28M | -82.73M | 1.60B | -18.85M | -6.73M | -1.17M | 1.13M | -3.25M | -619.48K |
| EBITDA Ratio | -82.30% | -64.40% | 29.81% | -342.66% | -5,917.22% | -100.74% | -23.20% | -284.94% | -1,769.80% | 0.00% | 316.69% |
| Operating Income | -84.80M | -116.01M | 6.79M | -179.35M | -121.48M | -13.29M | -1.68M | -1.23M | 540.34K | -3.08M | -619.48K |
| Operating Income Ratio | -97.20% | -126.23% | 9.12% | -383.88% | -511.51% | -115.32% | -51.64% | -297.13% | 238.47% | 0.00% | 316.69% |
| Total Other Income/Expenses | 11.13M | -18.55M | 129.46M | 146.11M | 1.32B | -478.00K | 3.78M | -82.85K | 132.31K | -1.11M | 0.00 |
| Income Before Tax | -73.67M | -134.56M | -397.14M | -73.27M | 1.17B | -13.74M | 2.22M | -1.31M | 155.05K | -4.15M | -619.48K |
| Income Before Tax Ratio | -84.44% | -146.41% | -533.53% | -156.84% | 4,907.68% | -119.19% | 68.32% | -317.23% | 68.43% | 0.00% | 316.69% |
| Income Tax Expense | -3.23M | 34.18M | -431.00K | 1.35M | -1.29B | 359.02K | 236.98K | -422.59K | -123.23K | 2.99M | 0.00 |
| Net Income | -73.96M | -168.73M | -396.70M | -74.62M | 2.46B | -13.93M | 1.98M | -885.40K | 278.28K | -4.15M | -619.48K |
| Net Income Ratio | -84.78% | -183.60% | -532.95% | -159.72% | 10,338.43% | -120.80% | 61.02% | -214.74% | 122.81% | 0.00% | 316.69% |
| EPS | -0.19 | -0.46 | -1.07 | -0.22 | 7.16 | -0.08 | -0.01 | -0.01 | 0.01 | -0.13 | -0.05 |
| EPS Diluted | -0.19 | -0.46 | -1.07 | -0.21 | 7.16 | -0.08 | -0.01 | -0.01 | 0.01 | -0.13 | -0.05 |
| Weighted Avg Shares Out | 380.96M | 370.39M | 369.73M | 345.18M | 342.81M | 172.27M | 134.80M | 78.25M | 36.41M | 31.95M | 12.75M |
| Weighted Avg Shares Out (Dil) | 380.96M | 370.39M | 370.39M | 351.58M | 342.81M | 172.27M | 176.79M | 78.25M | 43.69M | 32.24M | 12.75M |
Source: https://incomestatements.info
Category: Stock Reports